Stocks and Investing
Stocks and Investing
Tue, January 14, 2014
[ 12:00 AM ] - WOPRAI
Mon, January 13, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 10, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 9, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 8, 2014
[ 12:00 AM ] - WOPRAI
Christopher Marai Initiated (BIIB) at Strong Buy and Held Target at $368 on, Jan 8th, 2014
Christopher Marai of Nomura, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $368 on, Jan 8th, 2014.
Christopher has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Christopher
- Christopher Raymond of "Piper Sandler" Initiated at Buy on, Tuesday, November 26th, 2013
- Evan Seigerman of "Credit Suisse" Maintained at Buy and Held Target at $290 on, Friday, November 22nd, 2013
- Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $340 on, Friday, November 22nd, 2013